Smart Life Sciences Manufacturing Market Scope And Analysis

  • Report Code : TIPRE00029832
  • Category : Technology, Media and Telecommunications
  • Status : Published
  • No. of Pages : 212
Buy Now

Smart Life Sciences Manufacturing Market Scope and Analysis by 2033

Buy Now

Smart Life Sciences Manufacturing Market Report Smart Life Sciences Manufacturing Market Size and Share Smart Life Sciences Manufacturing Market Scope and Analysis

Smart Life Sciences Manufacturing Market Report Scope

Report Attribute Details
Market size in 2022 US$ 18.65 Billion
Market Size by 2033 US$ 78.97 Billion
Global CAGR (2022 - 2033) 14.4%
Historical Data 2020-2021
Forecast period 2023-2033
Segments Covered By Component
  • Solutions and Services
By Technology
  • AR/VR Systems
  • Internet of Things
  • Artificial Intelligence
  • Cybersecurity
  • Big Data
By Application
  • Pharma
  • Bio-Pharma
  • Medical Device
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • ABB Ltd
  • Bosch Rexroth AG
  • Emerson Electric Co
  • Fortinet Inc
  • General Electric Co
  • Honeywell International Inc
  • IBM Corporation
  • Rockwell Automation
  • Siemens AG

    • Smart life sciences manufacturing market players mainly focus on partnerships to create customer value.

    • In February 2023, Theragent, a cell therapy CDMO focused on advancing next-generation cancer and rare disease treatments, signed a multi-year exclusive contract with Insight68, an AI-driven software provider that aims to digitalize and streamline the cell therapy manufacturing process. The partnership reinforces Theragent's commitment to 100% digital batch record compliance and elevates the company's reputation as a leading CDMO in the current biopharma manufacturing transformation.
    • In December 2022, Hovione announced a strategic collaboration with GEA for Advance Continuous Tableting. Hovione is a company engaged in industrializing and democratizing emerging pharmaceutical technologies. It offers amorphous solid spray-dried dispersions converted into dependable and scalable offerings, made available to all.